Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Clarissa I Martinez"'
Autor:
Molly R. Braun, Clarissa I. Martinez, Emery G. Dora, Laura J. Showalter, Annette R. Mercedes, Sean N. Tucker
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
SARS-CoV-2 variant clades continue to circumvent antibody responses elicited by vaccination or infection. Current parenteral vaccination strategies reduce illness and hospitalization, yet do not significantly protect against infection by the more rec
Externí odkaz:
https://doaj.org/article/582c61b3445c4c029cc2944d425903bc
Autor:
Sarah N Tedjakusuma, Clarissa I Martinez, Adam Werts, Adriana E. Kajon, Emery G. Dora, Sean N. Tucker, Susan A. Johnson, Sharla M Birch, Nadine Peinovich
Publikováno v:
The Journal of Infectious Diseases
Background Vaccines that are shelf stable and easy to administer are crucial to improve vaccine access and reduce severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission around the world. Methods In this study, we demonstrate that a
Autor:
Stephanie N. Langel, Susan Johnson, Clarissa I. Martinez, Sarah N. Tedjakusuma, Nadine Peinovich, Emery G. Dora, Philip J. Kuehl, Hammad Irshad, Edward G. Barrett, Adam D. Werts, Sean N. Tucker
Publikováno v:
Science translational medicine. 14(658)
Transmission-blocking strategies that slow the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and protect against coronavirus disease 2019 (COVID-19) are needed. We have developed an orally delivered adenovirus type 5–vector
Autor:
Becca A. Flitter, Colin A. Lester, Sarah N. Tedjakusuma, Emery G. Dora, Nadine Peinovich, Mario Cortese, Clarissa I. Martinez, Clara B. Jegede, Elena D. Neuhaus, Sean N. Tucker
The emergence of SARS-CoV-2 variants continues to be a major obstacle for controlling the global pandemic. Despite the currently authorized SARS-CoV-2 vaccines ability to reduce severe disease and hospitalization, new immunization strategies are need
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::97d35d9a88481f92a219e10f3873380e
https://doi.org/10.1101/2022.02.21.481345
https://doi.org/10.1101/2022.02.21.481345
Autor:
Philip J. Kuehl, Stephanie N. Langel, Sean N. Tucker, Nadine Peinovich, Clarissa I Martinez, Adam Werts, Emery G. Dora, Susan D. Johnson, Hammad Irshad, Sarah N Tedjakusuma, Edward G. Barrett
Transmission-blocking strategies that slow the spread of SARS-CoV-2 and protect against COVID-19 are needed. We have developed a shelf-stable, orally-delivered Ad5-vectored SARS-CoV-2 vaccine candidate that expresses the spike protein. Here we demons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e773392397bea07dab9b997bcedb7df9
https://doi.org/10.1101/2021.10.03.462919
https://doi.org/10.1101/2021.10.03.462919
Autor:
Braun, Molly R., Martinez, Clarissa I., Dora, Emery G., Showalter, Laura J., Mercedes, Annette R., Tucker, Sean N.
Publikováno v:
Frontiers in Immunology; 2/22/2023, Vol. 14, p1-13, 13p
Autor:
Langel, Stephanie N., Johnson, Susan, Martinez, Clarissa I., Tedjakusuma, Sarah N., Peinovich, Nadine, Dora, Emery G., Kuehl, Philip J., Irshad, Hammad, Barrett, Edward G., Werts, Adam D., Tucker, Sean N.
Publikováno v:
Science Translational Medicine; 8/17/2022, Vol. 14 Issue 658, p1-11, 11p
Autor:
Johnson, Susan, Martinez, Clarissa I, Tedjakusuma, Sarah N, Peinovich, Nadine, Dora, Emery G, Birch, Sharla M, Kajon, Adriana E, Werts, Adam D, Tucker, Sean N
Publikováno v:
Journal of Infectious Diseases; 1/1/2022, Vol. 225 Issue 1, p34-41, 8p